Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Raw Materials (2016 - 2019)

Historic Raw Materials for Ironwood Pharmaceuticals (IRWD) over the last 4 years, with Q4 2019 value amounting to $65000.0.

  • Ironwood Pharmaceuticals' Raw Materials changed N/A to $65000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $65000.0, marking a year-over-year change of. This contributed to the annual value of $65000.0 for FY2019, which is N/A changed from last year.
  • As of Q4 2019, Ironwood Pharmaceuticals' Raw Materials stood at $65000.0.
  • In the past 5 years, Ironwood Pharmaceuticals' Raw Materials registered a high of $1.5 million during Q1 2017, and its lowest value of $65000.0 during Q4 2019.
  • Moreover, its 4-year median value for Raw Materials was $801500.0 (2016), whereas its average is $800750.0.
  • Its Raw Materials has fluctuated over the past 5 years, first plummeted by 7964.31% in 2018, then surged by 37889.61% in 2019.
  • Ironwood Pharmaceuticals' Raw Materials (Quarter) stood at $1.0 million in 2016, then surged by 49.8% to $1.5 million in 2017, then tumbled by 79.64% to $308000.0 in 2018, then crashed by 78.9% to $65000.0 in 2019.
  • Its Raw Materials stands at $65000.0 for Q4 2019, versus $1.1 million for Q3 2019 and $1.5 million for Q2 2019.